Lisata Therapeutics company info

What does Lisata Therapeutics do?
Lisata Therapeutics (NASDAQ:LSTA) is dedicated to developing innovative therapeutics for the treatment of cancer and other serious diseases. With a focus on crafting solutions that precisely target disease mechanisms, Lisata is at the forefront of creating next-generation treatments. Their projects span from early-stage research to advanced clinical trials, aiming to transform patient care and outcomes. Objectives include accelerating the development of their pipeline projects, expanding their research into new therapeutic areas, and establishing partnerships to enhance their reach and capabilities. Through relentless innovation and a commitment to excellence, Lisata Therapeutics strives to improve the quality of life for patients worldwide.
Lisata Therapeutics company media
Company Snapshot

Is Lisata Therapeutics a public or private company?

key
Ownership
Public

How many people does Lisata Therapeutics employ?

people
Employees
25

What sector is Lisata Therapeutics in?

pie chart
Sector
Health Care

Where is the head office for Lisata Therapeutics?

location pin
Head Office
New Jersey, United States

What year was Lisata Therapeutics founded?

founded flag
Year Founded
1980
What does Lisata Therapeutics specialise in?
/Gene Therapy /Rare Diseases /Genetic Disorders /Biotechnology Research /Therapeutic Development /Science Innovation

What are the products and/or services of Lisata Therapeutics?

Overview of Lisata Therapeutics offerings
Developing a unique delivery system for solid tumor treatment, leveraging targeted payload release.
Advancing a novel oncology pipeline with proprietary technology aimed at improving cancer treatment outcomes.
Creating personalized medicine solutions to enhance efficacy in cancer therapies.
Innovating in drug delivery platforms to minimize side effects and optimize therapeutic impact.
Collaborating on research projects with leading institutions to accelerate groundbreaking cancer treatments.
Expanding into biotechnology services to support drug development and clinical trials for oncology.

Who is in the executive team of Lisata Therapeutics?

Lisata Therapeutics leadership team
  • Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
    Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
    President, CEO & Director
  • Dr. Kristen K. Buck M.D.
    Dr. Kristen K. Buck M.D.
    Executive VP of R&D and Chief Medical Officer
  • Mr. James  Nisco
    Mr. James Nisco
    VP of Finance & Treasury
  • Mr. Tariq  Imam
    Mr. Tariq Imam
    Vice President of Business Development & Operations and Corporate Counsel
  • Mr. Gregory S. Berkin
    Mr. Gregory S. Berkin
    Chief Information Officer
  • Mr. John D. Menditto
    Mr. John D. Menditto
    Vice President of Investor Relations & Corporate Communications
  • Ms. Gail  Holler
    Ms. Gail Holler
    Vice President of Human Resources
  • Dr. William K. Sietsema Ph.D.
    Dr. William K. Sietsema Ph.D.
    Vice President of Global Regulatory Affairs